Researchers looked at whether a blood test that measures inflammation, called the systemic immune-inflammation index (SII), could help predict the risk of death in people who had an ischemic stroke. The study included 1,156 patients treated at a single hospital in China and followed them for a median of about 14 months. They found that 97 patients (8.4%) died during this time.
The main finding was that patients with higher SII levels had a higher risk of death. For every standard increase in the SII score, the risk of death increased by about 17%. When comparing the group with the highest SII scores to the group with the lowest, the risk was about 54% higher. The SII score was a slightly better predictor of death risk than two other similar inflammation markers.
It is important to be careful with these results. This was a retrospective study, meaning researchers looked back at existing patient records. This type of study can show a link or association, but it cannot prove that high inflammation caused the deaths. The study was done at just one hospital, so the results might not apply to all stroke patients everywhere. The SII score's predictive power on its own was modest, but it improved when combined with standard measures of stroke severity.
Readers should understand that this research suggests a connection between inflammation after a stroke and long-term survival. It does not mean that checking this specific inflammation marker is a standard or recommended test for stroke patients. More research in different settings is needed to see if this marker could be useful for doctors in the future.
